CNMD
CONMED Corp
NYSE · Healthcare · Medical - Devices · US
$46.47
+0.36%Price chart
Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9Sep 14
ValuationView details →
P/E (Fwd)
10.4x
EV/EBITDA
12.2x
Market Cap
$1.39B
MomentumView details →
1D Return
+0.36%
YTD Return
+14.10%
RSI (14)
40.4
ValuationView details →
P/E (Fwd)
10.4x
EV/EBITDA
12.2x
Market Cap
$1.39B
RSI (14)
40.4
MomentumView details →
1D Return
+0.36%
YTD Return
+14.10%
SummaryUpdated Jun 1, 2026
CONMED Corporation (NYSE:CNMD) is a medical technology company founded in 1970 and headquartered in Largo, Florida. The company went public in 1987 and has grown to become a significant player in the surgical device industry, developing, manufacturing, and selling surgical equipment and related products for procedures worldwide. CONMED has built its business through both organic growth and strategic acquisitions, including notable purchases of In2Bones and Biorez in 2022, which expanded its orthopedic capabilities. The company operates globally, serving hospitals, surgery centers, and other healthcare institutions directly and through medical specialty distributors.
Similar companies
Latest newsMore news →
CONMED Corporation reported financial results for the second quarter ended June 30, 2026, with sales of $343.5 million, up 0.3% year-over-year.47d agoCONMED Corporation announced that its AirSeal Robotic Solution has received an expanded FDA-cleared indication for use with Intuitive's 8 mm hex cannulas on the da Vinci 5 platform.54d agoCONMED Corporation repurchased approximately $645.2 million aggregate principal amount of its 2.25% Convertible Senior Notes due 2027 for about $637.2 million in cash.103d ago